vs

Side-by-side financial comparison of Community West Bancshares (CWBC) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

Community West Bancshares is the larger business by last-quarter revenue ($38.3M vs $26.6M, roughly 1.4× NeuroPace Inc). On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 11.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $409.0K). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs 21.1%).

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

CWBC vs NPCE — Head-to-Head

Bigger by revenue
CWBC
CWBC
1.4× larger
CWBC
$38.3M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+12.3% gap
NPCE
23.9%
11.6%
CWBC
More free cash flow
CWBC
CWBC
$43.2M more FCF
CWBC
$43.6M
$409.0K
NPCE
Faster 2-yr revenue CAGR
CWBC
CWBC
Annualised
CWBC
36.0%
21.1%
NPCE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWBC
CWBC
NPCE
NPCE
Revenue
$38.3M
$26.6M
Net Profit
$-2.7M
Gross Margin
77.4%
Operating Margin
40.0%
-6.6%
Net Margin
-10.3%
Revenue YoY
11.6%
23.9%
Net Profit YoY
48.0%
EPS (diluted)
$0.58
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWBC
CWBC
NPCE
NPCE
Q4 25
$38.3M
$26.6M
Q3 25
$37.9M
$27.4M
Q2 25
$35.7M
$23.5M
Q1 25
$34.8M
$22.5M
Q4 24
$34.3M
$21.5M
Q3 24
$31.3M
$21.1M
Q2 24
$30.5M
$19.3M
Q1 24
$20.7M
$18.1M
Net Profit
CWBC
CWBC
NPCE
NPCE
Q4 25
$-2.7M
Q3 25
$10.9M
$-3.5M
Q2 25
$7.8M
$-8.7M
Q1 25
$8.3M
$-6.6M
Q4 24
$-5.3M
Q3 24
$3.4M
$-5.5M
Q2 24
$-6.3M
$-7.5M
Q1 24
$3.7M
$-8.9M
Gross Margin
CWBC
CWBC
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
CWBC
CWBC
NPCE
NPCE
Q4 25
40.0%
-6.6%
Q3 25
39.8%
-9.5%
Q2 25
30.2%
-29.0%
Q1 25
32.7%
-22.9%
Q4 24
31.0%
-17.0%
Q3 24
13.3%
-20.1%
Q2 24
-25.9%
-32.4%
Q1 24
23.2%
-41.6%
Net Margin
CWBC
CWBC
NPCE
NPCE
Q4 25
-10.3%
Q3 25
28.7%
-12.8%
Q2 25
22.0%
-36.8%
Q1 25
23.8%
-29.3%
Q4 24
-24.5%
Q3 24
10.8%
-25.9%
Q2 24
-20.7%
-39.0%
Q1 24
17.8%
-49.2%
EPS (diluted)
CWBC
CWBC
NPCE
NPCE
Q4 25
$0.58
$-0.08
Q3 25
$0.57
$-0.11
Q2 25
$0.41
$-0.26
Q1 25
$0.44
$-0.21
Q4 24
$0.29
$-0.16
Q3 24
$0.18
$-0.19
Q2 24
$-0.33
$-0.26
Q1 24
$0.31
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWBC
CWBC
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$119.0M
$61.1M
Total DebtLower is stronger
$69.5M
Stockholders' EquityBook value
$409.6M
$19.0M
Total Assets
$3.7B
$105.6M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWBC
CWBC
NPCE
NPCE
Q4 25
$119.0M
$61.1M
Q3 25
$121.6M
$60.0M
Q2 25
$134.4M
$62.1M
Q1 25
$148.4M
$66.3M
Q4 24
$120.4M
$52.8M
Q3 24
$149.0M
$56.8M
Q2 24
$109.7M
$55.5M
Q1 24
$61.0M
$58.9M
Total Debt
CWBC
CWBC
NPCE
NPCE
Q4 25
$69.5M
Q3 25
Q2 25
Q1 25
Q4 24
$69.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWBC
CWBC
NPCE
NPCE
Q4 25
$409.6M
$19.0M
Q3 25
$397.6M
$18.5M
Q2 25
$380.0M
$19.4M
Q1 25
$372.2M
$24.3M
Q4 24
$362.7M
$8.0M
Q3 24
$363.5M
$9.8M
Q2 24
$350.2M
$9.9M
Q1 24
$211.7M
$14.3M
Total Assets
CWBC
CWBC
NPCE
NPCE
Q4 25
$3.7B
$105.6M
Q3 25
$3.6B
$107.3M
Q2 25
$3.6B
$106.1M
Q1 25
$3.6B
$110.2M
Q4 24
$3.5B
$94.6M
Q3 24
$3.5B
$96.3M
Q2 24
$3.5B
$94.4M
Q1 24
$2.4B
$98.9M
Debt / Equity
CWBC
CWBC
NPCE
NPCE
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWBC
CWBC
NPCE
NPCE
Operating Cash FlowLast quarter
$46.1M
$506.0K
Free Cash FlowOCF − Capex
$43.6M
$409.0K
FCF MarginFCF / Revenue
113.9%
1.5%
Capex IntensityCapex / Revenue
6.6%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$77.7M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWBC
CWBC
NPCE
NPCE
Q4 25
$46.1M
$506.0K
Q3 25
$13.2M
$-1.9M
Q2 25
$11.5M
$-2.1M
Q1 25
$11.1M
$-7.5M
Q4 24
$22.2M
$-4.8M
Q3 24
$7.8M
$-1.7M
Q2 24
$5.2M
$-3.9M
Q1 24
$4.0M
$-7.5M
Free Cash Flow
CWBC
CWBC
NPCE
NPCE
Q4 25
$43.6M
$409.0K
Q3 25
$12.8M
$-2.0M
Q2 25
$10.6M
$-2.3M
Q1 25
$10.8M
$-7.5M
Q4 24
$17.2M
$-4.8M
Q3 24
$5.2M
$-1.8M
Q2 24
$4.8M
$-4.0M
Q1 24
$3.6M
$-7.6M
FCF Margin
CWBC
CWBC
NPCE
NPCE
Q4 25
113.9%
1.5%
Q3 25
33.7%
-7.2%
Q2 25
29.6%
-9.6%
Q1 25
30.9%
-33.4%
Q4 24
50.0%
-22.5%
Q3 24
16.7%
-8.7%
Q2 24
15.7%
-20.6%
Q1 24
17.3%
-42.1%
Capex Intensity
CWBC
CWBC
NPCE
NPCE
Q4 25
6.6%
0.4%
Q3 25
1.1%
0.1%
Q2 25
2.7%
0.7%
Q1 25
0.9%
0.2%
Q4 24
14.7%
0.2%
Q3 24
8.1%
0.5%
Q2 24
1.4%
0.3%
Q1 24
2.1%
0.6%
Cash Conversion
CWBC
CWBC
NPCE
NPCE
Q4 25
Q3 25
1.21×
Q2 25
1.47×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
Q2 24
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons